Navigation Links
Formedix Partners With OpenClinica to Deliver Automated End-to-End Clinical Trial Builds
Date:10/25/2013

Burlington, MA (PRWEB) October 25, 2013

Formedix, leading provider of clinical trial automation software and consultancy services is excited to announce a new partnership with OpenClinica, LLC, producers of the world’s most widely used open source electronic data capture software. The two companies are collaborating to offer an integration between Formedix Origin universal clinical trial design tools and OpenClinica’s uniquely flexible open source system for Electronic Data Capture (EDC) and Clinical Data Management.

The product, named Formedix Transform for OpenClinica, reaches the market this week and joins the company’s ever-expanding range of integrations with the leading EDC systems on the market. Transform for OpenClinica, a new integration with Formedix Universal Design Tool, Origin, merges study specification and EDC build into one process to significantly reduce OpenClinica study build times--in some cases by more than 55%. Other capabilities include study build automation and drag-and-drop reuse, enhanced by leveraging portable, vendor neutral CDISC designs.

CROs and sponsors now have even greater choice when selecting an EDC system with the introduction of Transform for OpenClinica and its diverse capabilities. There is no longer a need for training and support in multiple systems because, with Formedix, training only needs to be given for one study design tool.

Earlier this year, Mark Wheeldon, CEO of Formedix, was invited to present at OC13, the 2013 OpenClinica Global Conference, discussing the use of CDISC standards to drive efficiencies in study set-up and build with OpenClinica. He also spoke in detail about how Formedix is working with partners, such as OpenClinica, to develop cutting-edge solutions to help achieve further reductions in study build times.

Mark said, “Formedix Transform enables users to design in one environment and interface with multiple systems, broadening the scope of CROs and EDC vendors. By providing a vendor neutral solution, our customers can choose one, work with all. Transform for OpenClinica will allow us to continue our ongoing mission of delivering more choice for study build, as well as reducing the need for training in multiple systems.”

He added, “We are delighted to add to our wide portfolio of Transform tools and partner with OpenClinica, to offer even more choice to our customers. We are the only independent provider of multi-vendor solutions for clinical trial automation and we continue to build our network of technology partnerships to enhance this proposition.”

Contact Formedix for more information about the universal design and build tools, or to express an interest in partnering with the company to build an EDC integration.

About Formedix

Formedix clinical trial automation software and services enable you to remove manual, expensive, inefficient and labor intensive tasks from study set-up, EDC build, validation and submission publication processes.

In fact, across every facet of your end-to-end clinical trial, the time and cost savings they deliver speak for themselves and continue to do so time and time again.

Formedix saves 68% in set-up time and 55% in EDC build time. With 70% reuse of your content, resources are cut by 23%. It’s all in the numbers.

Your Clinical Trials Automated. Everywhere.

About OpenClinica

OpenClinica, LLC is the global leader in open source EDC | CDMS software with thousands of implementations at contract research organizations, biopharmaceutical companies, academic, and government organizations. The powerful tools and superior quality system increase the speed of data collection and ensure data integrity in clinical trials. OpenClinica supports ICH, GCP, 21 CFR Part 11, HIPAA, and other regulatory guidelines, and is designed as a standards-based, extensible, and modular platform.

For more information visit https://www.openclinica.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11246150.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
2. Take a Standards Health Check with Formedix at DIA 49th Annual Meeting
3. Formedix to Host Executive Breakfast prior to Bay Area CDISC Network Meeting, May 23, 2013
4. Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
5. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
6. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
7. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 2012
8. Clinical Conductor CTMS Partners with the Greater Gift Initiative to Donate Vaccines
9. Samsung BioLogics unterzeichnet strategische Herstellungspartnerschaft mit Roche
10. Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche
11. QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):